Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy

Detalles Bibliográficos
Autores principales: Lorenzo, Giuseppe Di, Scafuri, Luca, Costabile, Ferdinando, Pepe, Liuba, Scognamiglio, Anna, Crocetto, Felice, Guerra, Germano, Buonerba, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890115/
https://www.ncbi.nlm.nih.gov/pubmed/35251698
http://dx.doi.org/10.2144/fsoa-2022-0002
_version_ 1784661560716689408
author Lorenzo, Giuseppe Di
Scafuri, Luca
Costabile, Ferdinando
Pepe, Liuba
Scognamiglio, Anna
Crocetto, Felice
Guerra, Germano
Buonerba, Carlo
author_facet Lorenzo, Giuseppe Di
Scafuri, Luca
Costabile, Ferdinando
Pepe, Liuba
Scognamiglio, Anna
Crocetto, Felice
Guerra, Germano
Buonerba, Carlo
author_sort Lorenzo, Giuseppe Di
collection PubMed
description
format Online
Article
Text
id pubmed-8890115
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Future Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-88901152022-03-04 Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy Lorenzo, Giuseppe Di Scafuri, Luca Costabile, Ferdinando Pepe, Liuba Scognamiglio, Anna Crocetto, Felice Guerra, Germano Buonerba, Carlo Future Sci OA Editorial Future Science Ltd 2022-02-11 /pmc/articles/PMC8890115/ /pubmed/35251698 http://dx.doi.org/10.2144/fsoa-2022-0002 Text en © 2022 Carlo Buonerba https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Lorenzo, Giuseppe Di
Scafuri, Luca
Costabile, Ferdinando
Pepe, Liuba
Scognamiglio, Anna
Crocetto, Felice
Guerra, Germano
Buonerba, Carlo
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title_full Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title_fullStr Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title_full_unstemmed Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title_short Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
title_sort fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890115/
https://www.ncbi.nlm.nih.gov/pubmed/35251698
http://dx.doi.org/10.2144/fsoa-2022-0002
work_keys_str_mv AT lorenzogiuseppedi fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT scafuriluca fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT costabileferdinando fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT pepeliuba fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT scognamiglioanna fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT crocettofelice fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT guerragermano fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy
AT buonerbacarlo fisetinasanadjuvanttreatmentinprostatecancerpatientsreceivingandrogendeprivationtherapy

Ejemplares similares